Arbutus Biopharma Corp (ABUS) NPV
1.20%- This stock can be held in a
Stocks and Shares ISASell:$3.17
Buy:$3.18
Change:
$0.11
(3.59%)
$0.11
(3.59%)Market closed | Prices delayed by at least 15 minutes
Sell:$3.17
Buy:$3.18
Change:$0.11
(3.59%)
$0.11
(3.59%)Market closed | Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 4 February 2025 | Michael John McElhaughChief Level Officer | Sell Tax related | 23,790 | $3.28 | $78,102.57 | 1,481,003 |
| 4 February 2025 | David Cummins HastingsCFO | Sell Tax related | 22,183 | $3.28 | $72,826.79 | 159,724 |
| 4 February 2025 | Karen SimsOther Level A | Sell Tax related | 19,348 | $3.28 | $63,519.48 | 106,194 |
| 4 February 2025 | John Christopher NaftzgerGeneral Counsel | Sell Tax related | 11,333 | $3.28 | $37,206.24 | 86,244 |
| 31 December 2024 | John Christopher NaftzgerGeneral Counsel | Buy Regular purchase transaction | 2,477 | $1.74 | $4,309.98 | 97,577 |
| 14 August 2024 | Keith Simon ManchesterIndependent Director | Sell Option/Award related | 8,846 | $3.69 | $32,637.32 | 46,069 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 4 February 2025 | Michael John McElhaughChief Level Officer | Sell Tax related | 23,790 | $3.28 | $78,102.57 | 1,481,003 |
| 4 February 2025 | David Cummins HastingsCFO | Sell Tax related | 22,183 | $3.28 | $72,826.79 | 159,724 |
| 4 February 2025 | Karen SimsOther Level A | Sell Tax related | 19,348 | $3.28 | $63,519.48 | 106,194 |
| 4 February 2025 | John Christopher NaftzgerGeneral Counsel | Sell Tax related | 11,333 | $3.28 | $37,206.24 | 86,244 |
| 14 August 2024 | Keith Simon ManchesterIndependent Director | Sell Option/Award related | 8,846 | $3.69 | $32,637.32 | 46,069 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.